Observation of the clinical features of dupilumab-associated facial erythema

Observation of the clinical features of dupilumab-associated facial erythema

Bibliographic Details
Main Authors:	Hao Wu, Weiming Zhang, Zhongxiao Wu, Yanna Shen, Li Zhang, Mouzhe Yang, Yougang Ren, Feng Mao
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-01-01
Series:	Advances in Dermatology and Allergology
Subjects:	atopic dermatitis dupilumab facial erythema facial redness flushing
Online Access:	https://www.termedia.pl/Observation-of-the-clinical-features-of-dupilumab-associated-facial-erythema,7,51692,1,1.html

Similar Items

Facial erythema after the treatment of dupilumab in SLE patient
by: Dong Hyek Jang, et al.
Published: (2020-07-01)

Dupilumab-associated facial erythema successfully treated with oral ivermectin
by: Javier Gil-Lianes, et al.
Published: (2022-10-01)

Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
by: Takeshi Fukumoto, et al.
Published: (2022-12-01)

Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis
by: Hye Sung Han, et al.
Published: (2023-12-01)

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series
by: Shuhei Hara, MD, et al.
Published: (2023-05-01)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01)

Rosacea associated with dupilumab therapy
by: Haley D. Heibel, et al.
Published: (2021-01-01)

Dupilumab side effect in a patient with atopic dermatitis: a case report study
by: Albader SS, et al.
Published: (2019-05-01)

Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab
by: Kamran Ali, et al.
Published: (2022-07-01)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022-01-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023-03-01)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020-05-01)

Dupilumab for atopic dermatitis treatment: A single-center retrospective study
by: Gülbin Yaşar, et al.
Published: (2022-03-01)

Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
by: Vingopoulos F, et al.
Published: (2020-07-01)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
by: Yolanka Lobo, et al.
Published: (2021-05-01)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018-03-01)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022-11-01)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
by: Yutaka Inaba, et al.
Published: (2022-02-01)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023-01-01)

Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
by: Jowita Sroka-Tomaszewska, et al.
Published: (2024-01-01)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
by: Chen J, et al.
Published: (2023-08-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

Dupilumab-associated cicatrizing ocular disease
by: Amit K. Reddy, et al.
Published: (2022-06-01)

Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
by: Paweł Iwańczuk
Published: (2024-02-01)

Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks
by: Claudia Paganini, et al.
Published: (2024-02-01)

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2023-10-01)

Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
by: T. Torres, et al.
Published: (2022-07-01)

Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy
by: S. Ferrucci, et al.
Published: (2021-05-01)

A case of infective endocarditis associated with atopic dermatitis perioperatively treated with dupilumab
by: Mika Nakanishi, et al.
Published: (2019-10-01)

The use of dupilumab in severe atopic dermatitis during pregnancy: a case report
by: Nabeel H. Akhtar, et al.
Published: (2022-02-01)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020-12-01)

Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023-12-01)

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
by: Wang M, et al.
Published: (2024-03-01)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022-05-01)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024-03-01)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022-11-01)

Dupilumab-Associated Blepharoconjunctivitis: Clinical and Morphological Aspects
by: Federica Serino, et al.
Published: (2023-11-01)